Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D09AUU
|
|||
Former ID |
DNC000565
|
|||
Drug Name |
Dimemorfan
|
|||
Synonyms |
Dimemorfan (INN); 36309-01-0; SCHEMBL509122
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C18H25N
|
|||
Canonical SMILES |
CC1=CC2=C(CC3C4C2(CCCC4)CCN3C)C=C1
|
|||
InChI |
1S/C18H25N/c1-13-6-7-14-12-17-15-5-3-4-8-18(15,16(14)11-13)9-10-19(17)2/h6-7,11,15,17H,3-5,8-10,12H2,1-2H3/t15-,17+,18+/m1/s1
|
|||
InChIKey |
KBEZZLAAKIIPFK-NJAFHUGGSA-N
|
|||
CAS Number |
CAS 36309-01-0
|
|||
PubChem Compound ID | ||||
PubChem Substance ID | ||||
ChEBI ID |
CHEBI:135048
|
|||
SuperDrug ATC ID |
R05DA11
|
|||
SuperDrug CAS ID |
cas=036309010
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Opioid receptor sigma 1 (OPRS1) | Target Info | Agonist | [1] |
WikiPathways | miR-targeted genes in squamous cell - TarBase | |||
miR-targeted genes in lymphocytes - TarBase |
References | Top | |||
---|---|---|---|---|
REF 1 | Dimemorfan protects rats against ischemic stroke through activation of sigma-1 receptor-mediated mechanisms by decreasing glutamate accumulation. J Neurochem. 2008 Jan;104(2):558-72. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.